Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis

NCT05634057 is registered in ClinicalTrials.gov with Chen Ying as lead sponsor.

NCT NCT05634057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05634057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
Lead sponsor
Chen Ying
Phase
Not applicable
Overall status
Recruiting
Start date
January 25, 2024
Completion date
December 31, 2025
Enrollment
782 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis